The deadline for applications for McDonald fellowships and Du Pré Grants is 30 June 2018
Tools for the #bringinguscloser campaign for World MS Day 2018 are now available to download.
The Association for the Fight Against MS (ALCEM) presents the Miguel Pablo Gallardo award and the Proyecto Investigación (Research Project) award.
The European Commission has approved the first disease-modifying therapy, ocrelizumab, for early primary progressive MS (PPMS).
MSIF is proud to announce the recipients of the 2017 McDonald fellowships and Du Pre grants
Chemistry of brain inflammation linked to mood changes in MS
Prof. Sørensen, one of the world’s prominent clinical neurologists in multiple sclerosis, recognised for lifetime achievement in improving understanding and treatment of MS.
A meeting of minds took place at the recent International Progressive MS Alliance event in London
Diagnosis of MS is getting faster and more efficient but new research suggests there are still ways to improve diagnosis
A new study recently published uses ‘real-world’ data to investigate the effects of disease modifying therapies on secondary progressive MS